蓝帆医疗股份有限公司 关于公司为子公司向银行申请授信提供担保的进展公告

Group 1 - The company plans to apply for a total credit limit of up to RMB 3 billion for 2026, which includes various types of financing such as working capital loans and guarantees [2] - The company will provide guarantees for its subsidiaries, with a maximum guarantee amount of RMB 2.8 billion for subsidiaries with a debt-to-asset ratio below 70% and RMB 200 million for those at or above 70% [2] - The guarantees will be valid for 12 months from the date of the shareholders' meeting resolution [2] Group 2 - The company's wholly-owned subsidiary, Shandong Lanfang New Materials Co., Ltd., has applied for a one-year loan from Industrial Bank Co., Ltd., and the company has signed a maximum guarantee contract for this loan [4] - The total amount of guarantees provided will not exceed the approved limit from the shareholders' meeting, thus no additional board or shareholder meetings are required [4] - As of the announcement date, the total guarantee amount for the company and its subsidiaries is RMB 3,539.33 million, which accounts for 43.23% of the company's audited net assets for 2024 [9] Group 3 - The company issued a total of 31,440,400 convertible bonds, with a total issuance amount of RMB 314.404 million [13] - In the fourth quarter of 2025, the company saw a reduction of RMB 61,000 in convertible bonds due to conversion, resulting in an increase of 5,957 shares [17] - The total balance of convertible bonds as of December 31, 2025, is RMB 1,520,378,200 [17]

BLUE SAIL MEDICAL-蓝帆医疗股份有限公司 关于公司为子公司向银行申请授信提供担保的进展公告 - Reportify